Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Berberine × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adenocarcinoma of Lung 1

Interventions

Carboplatin 61 Paclitaxel 42 Radiotherapy 39 Cisplatin 37 Pemetrexed 36 Bevacizumab 36 Docetaxel 25 Gemcitabine 24 Erlotinib Hydrochloride 20 Gefitinib 17 pembrolizumab 13 Taxes 10 Cetuximab 10 Magnetic Resonance Spectroscopy 8 Vinorelbine 7 Nivolumab 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 Radiosurgery 6 Radiation 6 Platinum 6 Etoposide 6 capmatinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Cyclophosphamide 5 Biopsy 5 ceritinib 4 aflutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03486496 2018-04-03

Geber

Fujian Cancer Hospital

Phase 2 Unknown

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡